Target intelligence / Profile preview

Acylphosphatase 2 (ACYP2)

Target
ACYP2
Molecular classification
Enzyme
01

Overview

Acylphosphatase 2 (ACYP2) is a small multifunctional enzyme that catalyzes the hydrolysis of acyl-phosphate bonds and plays important roles in intracellular calcium homeostasis, energy metabolism, and cell differentiation. The enzyme can hydrolyze the phosphoenzyme intermediate of different membrane pumps, particularly the Ca2+/Mg2+-ATPase from sarcoplasmic reticulum of skeletal muscle. ACYP2 exhibits dual subcellular localization, functioning in both the cytoplasm and nucleus of cells. In the cytoplasm, ACYP2 regulates potassium calcium-activated channel subfamily N member 4 (KCNN4), inhibiting K+ efflux and subsequent inactivation of the ERK pathway, which impedes tumor growth and metastasis. In the nucleus, ACYP2 inhibits telomerase reverse transcriptase (TERT) activity, leading to telomere shortening and reversal of cell immortalization. ACYP2 represents an innovative therapeutic target, particularly for hepatocellular carcinoma, where restoration of its expression through targeted delivery systems has shown promising results in preclinical models. The enzyme's multifaceted roles in cellular signaling, telomere maintenance, and disease susceptibility position it as a critical mediator linking fundamental enzymatic activity with broader aspects of human health and disease.

Other names
acylphosphatase 2 muscle typeacylphosphate phosphohydrolase 2ACYMACYPacylphosphatase muscle type isozymetesticular tissue protein Li 11
02

Mechanism of action

Gene therapy approaches using pcDNA-ACYP2 vectors have been developed, with novel targeted nanotherapy strategies involving encapsulation within polyetherimide nanoparticles coated with HCC cell membranes

03

Biological functions

Signal transductionCell proliferationCell deathApoptosis
04

Disease associations

Cancer
05

Safety considerations

Genetic variants may predispose to cisplatin-induced ototoxicity
06

Biomarkers

ACYP2 expression level shows diagnostic potential for hepatocellular carcinoma with an area under the ROC curve of 0.826

Beyond the preview

Go deeper on Acylphosphatase 2 (ACYP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acylphosphatase 2 (ACYP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call